In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

“Once in a while you get shown ... reports of reduced drug cravings and decreased drug-related rewards, including reduced sensations of pleasure. In and of itself, this new research does not ...

Eli Lilly on Thursday suggested that demand for its popular diabetes and weight-loss treatments was not a concern, easing ...

Americans are split on using weight loss drugs such as Ozempic and Wegovy to treat obesity or weight-related conditions, ...

Weight loss drugs ... new studies as more confirmatory or educationally to refer patients to some beneficial parts of the medication. What do you recommend for patients who drink alcohol and also ...